Find similar content

Source channel @githubtrending · Post #14714 · May 16

#go#compression#decompression#deflate#go#golang#gzip#snappy#zip#zstandard#zstd The "github.com/klauspost/compress" package offers many fast and efficient compression tools in pure Go, including zstandard, S2 (a faster Snappy replacement), optimized deflate for gzip/zip/zlib, and snappy with better compression and concurrency. It also provides entropy encoders (huff0, FSE), HTTP gzip handlers, and a parallel gzip implementation (pgzip). These tools are drop-in replacements for Go's standard libraries but run about twice as fast, saving time and resources. You can easily add it to your project with `go get`. It supports current and recent Go versions and offers options to disable unsafe code or assembly for compatibility. This package benefits you by improving compression speed and efficiency while maintaining compatibility with standard Go compression APIs, making your applications faster and more resource-friendly. https://github.com/klauspost/compress

Hashtags

#go #compression #decompression #deflate #golang #gzip #snappy #zip #zstandard #zstd

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment